... a focused investment on Life Science
Thank you for your interest in our products and services.
The range of investment funds that we can show you or offer you depends on the laws of your country of residence and the regulatory environment to which you are subject. We can further only offer investment funds that have been market-approved for your country of residence and your investor category.
Continuing in this password protected site means that you have lawfully received your User ID and Password, supporting documents including but not limited to the prospectus and the annual report and that you have accepted all the terms and conditions.
These funds are domiciled in the Principality of Liechtenstein. Due to different registration proceedings, no guarantee can be given that the fund and – if applicable – sub-funds are or will be registered in every jurisdiction and at the same time. Please note, that in any country where a fund is not registered for public offering, they may, subject to applicable local regulation, only be distributed in the course of ‘private placements’ or institutional investments and for 'qualified investors only'. Shares in funds are not offered for sale in countries where such sale is prohibited by law.
These funds are not registered under the United States Securities Act of 1933. Fundunits must therefore not be offered or sold in the United States neither for or on account of US persons (in the context of the definitions for the purposes of US federal laws on securities, goods and taxes, including Regulation S in relation to the United States Securities Act of 1933). Subsequent unit transfers in the United States and/or to US persons are not permitted. Any documents related to this fund must not be circulated in the United States.
These funds are not registered in Switzerland for distribution. They can only be purchased by FINMA regulated financial intermediaries as defined in the CISA Act (Federal Act on Collective Investments Schemes).
To request your password please download and send us back this form.